N,N'-((3S,4S)-pyrrolidine-3,4-diyl)diacetamide, 98.0%, 1g

6-Chloro-4-methyl-3-nitropyridin-2-amine, 95.0%, 250mg

Cetyltrimethylammonium bromide (CTAB), 1 kg

h-d-glu(otbu)-ome.hcl, 95.0%, 1g

3-Amino- N , N -diethyl-benzenesulfonamide, 95.0%, 250mg

1,3,3-Trimethylindolinonaphthospirooxazine>98.0%(HPLC)(T)1g

Precision Scale Models FX Series with External Calibration, 0.01 g, 1220 g, FX-1200i (W)

(3-Chlorophenyl)methanesulfonamide, 97%, 250mg

(S)-4-(6-(3,5-Dimethylisoxazol-4-yl)-1-(1-(pyridin-2-yl)ethyl)-1H-pyrrolo[3,2-b]pyridin-3-yl)benzoic acid, 98.00%, 1mg

(S)-2-Aminopent-4-ynoic acid, 95.0%, 100mg

3-amino-N-((3-isopropyl-1,2,4-oxadiazol-5-yl)methyl)propanamide hydrochloride, 95.0%, 250mg

2-Bromo-4-fluoro-1-iodobenzene, 98.0%, 25g

5-Cyclopropylpyrimidin-2-amine, 97%, 500mg